Enter assignee name

CIPO Patents = 4

Trademarks = 1

Forward Citations = 204

Loading Chart...

3 inventors (with patents filed for the assignee):

Nirmal Mulye (9 out of 24 patents)

John S Lomans (1 out of 4 patents)

Kavita Inamdar (1 out of 3 patents)

10 patents: Sort by Forward Citations

1. 10391419 - Isolation and purification of conjugated estrogens (2019-08-27),

2. 8906419 - Pharmaceutical composition containing water soluble drug (2014-12-09),

3. 8545882 - Control release formulation containing a hydrophobic material as the sustained release agent (2013-10-01),

4. 8507000 - Controlled release formulation of erythromycin derivatives (2013-08-13),

5. 7897179 - Pharmaceutical composition containing water soluble drug (2011-03-01),

6. 7179486 - Process for preparing sustained release tablets (2007-02-20),

7. 7052706 - Control release formulation containing a hydrophobic material as the sustained release agent (2006-05-30),

8. 6946146 - Coating for a sustained release pharmaceutical composition (2005-09-20),

9. 6635680 - Controlled release pellet formulation (2003-10-21),

10. 6416786 - Sustained release tablet containing hydrocolloid and cellulose ether (2002-07-09),

Nostrum Pharmaceuticals, Inc. is a leading pharmaceutical company focused on developing and commercializing generic and specialty pharmaceutical products. With a strong commitment to quality and innovation, Nostrum Pharmaceuticals strives to improve patient outcomes and provide affordable healthcare solutions. The company's diverse product portfolio includes a wide range of prescription medications for various therapeutic areas.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

10 Patents

#17 in Edison, NJ

#1,098 in New Jersey

#28,952 in US

#54,268 in the World

Edison, NJ, United States of America

Nostrum Pharmaceuticals, Inc.

Forward Citations = 204

3 inventors:

Nirmal Mulye (9 out of 24 patents)

John S Lomans (1 out of 4 patents)

Kavita Inamdar (1 out of 3 patents)

Please report any incorrect information to support@idiyas.com